PDF《Livzon Pharmaceutical Group Inc.》

2012 semi-annual report of Livzon Pharmaceutical Group Inc.

4 Section Section Section Section

3 3

3 3 Financial Financial Financial Financial Highlights Highlights Highlights Highlights (I). (I). (I). (I).Main Main Main Main financial financial financial financial data data data data in in in in the the the the report report report report period period period period Are there any retrospective adjustments in the financial statements for previous reporting periods? Yes √ No Main financial data Main financial indexes ng Wen Hui Daily (English version) Website appointed by China Securities Regulatory Commission for publishing the semi-annual report http://www.cninfo.com.cn Location for filing the report Secretary'

s Office of BOD of Livzon Group Main financial data Report period (January to June) Same period of previous year Increase or decrease compared with the same period of previous year (%) Total operating income(RMB Yuan) 1,884,997,175.44 1,471,437,500.63 28.11% Operating profit(RMB Yuan) 282,068,231.88 261,244,259.11 7.97% Total profit(RMB Yuan) 294,403,930.28 283,241,156.20 3.94% Net profit attributable to the shareholders of listed companies 228,705,016.39 220,861,695.59 3.55% Net profit attributable to the shareholders of listed companies after deduction of non-recurring profit and loss 217,680,844.35 201,827,805.96 7.85% Net cash flows from operating activities (RMB Yuan) 335,416,385.94 292,654,480.77 14.61% End of the current period End of the previous year Increase or decrease compared wit........